Pharmalogyx Managing Director Colte Koen tells Proactive Investors the company is looking to raise $21 million in capital to launch full-scale production in both cultivation and processing at its Nevada-based CBD Hemp farm.

Koen says the company’s differentiator is their minimization of risk variables and ability to maximize profits through industrialization and scale.

Watch Video

Pharmalogyx CEO Colte Koen Talks with Proactive Investors in NYC
Pharmalogyx CEO Colte Koen Talks with Proactive Investors in NYC

 

Recent Posts

Pharmalogyx Seeks $21M to Launch 740 Acre Industrialized CBD Hemp Farm

Pharmalogyx Managing Director Colte Koen tells Proactive Investors the company is looking to raise $21 million in capital…

Legal Hemp In 2019 May Be A Boon For Stressed Out American Farmers

Legal hemp is about to¬†enter the American scene in a big way. The 2018 Farm Bill, which includes…